ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
ORTX
Delisted
ORTX was delisted on the 23rd of January, 2024.
47 hedge funds and large institutions have $24.7M invested in Orchard Therapeutics plc American Depositary Shares in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
47
Holding in Top 10
–
Calls
$6K
Puts
–
Top Buyers
| 1 | +$1.34M | |
| 2 | +$1.13M | |
| 3 | +$418K | |
| 4 |
Renaissance Technologies
New York
|
+$275K |
| 5 |
MIAN
Mariner Independent Advisor Network
Overland Park,
Kansas
|
+$258K |
Top Sellers
| 1 | -$1.94M | |
| 2 | -$1.78M | |
| 3 | -$685K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$360K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$330K |